Search details
1.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Article
in English
| MEDLINE | ID: mdl-35405085
2.
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 383(24): 2345-2357, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-32955174
3.
Chromogranin A: a useful biomarker in castration-resistant prostate cancer.
World J Urol
; 41(2): 361-369, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36527470
4.
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
World J Urol
; 41(8): 2033-2041, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36484817
5.
Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
World J Urol
; 41(3): 641-651, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-35835886
6.
Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center.
Acta Oncol
; 62(12): 1905-1912, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37948066
7.
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(3): 393-405, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35157830
8.
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
World J Urol
; 40(12): 2931-2937, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36342512
9.
Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic).
World J Urol
; 40(2): 419-425, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34773475
10.
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience.
BMC Cancer
; 19(1): 1182, 2019 Dec 03.
Article
in English
| MEDLINE | ID: mdl-31795959
11.
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
BMC Cancer
; 18(1): 194, 2018 02 17.
Article
in English
| MEDLINE | ID: mdl-29454321
12.
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
BMC Cancer
; 15: 222, 2015 Apr 04.
Article
in English
| MEDLINE | ID: mdl-25884302
13.
Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients.
J Negat Results Biomed
; 14: 18, 2015 Nov 10.
Article
in English
| MEDLINE | ID: mdl-26555878
14.
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Lancet Oncol
; 15(13): 1442-1450, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25456363
15.
Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamide.
Future Oncol
; 10(14): 2121-5, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25471026
16.
The testosterone replacement therapy for prostate cancer patients: Time to take the leap?
Andrology
; 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38725042
17.
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
NEJM Evid
; 3(1): EVIDoa2300171, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38320513
18.
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Eur Urol
; 85(3): 274-282, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37271630
19.
Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and Protocol.
Eur Urol Oncol
; 2023 Oct 06.
Article
in English
| MEDLINE | ID: mdl-37806843
20.
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer.
Pharmaceutics
; 15(2)2023 Feb 15.
Article
in English
| MEDLINE | ID: mdl-36839973